Rose Crane, CEO of Melanoma Diagnostics Provider, MELA Sciences, to Be Interviewed Live Today on Clear Channel Business Talk

Rose Crane, CEO of Melanoma Diagnostics Provider, MELA Sciences, to Be 
Interviewed Live Today on Clear Channel Business Talk Radio
DFW1190AM 
Interview at 1:05 pm CST / 2:05 pm EST on The Traders Network Radio
Show, Hosted by Michael Yorba 
DALLAS, TX and IRVINGTON, NY -- (Marketwired) -- 02/25/14 --  MELA
Sciences, Inc. (NASDAQ: MELA), developer of MelaFind(R), an FDA
approved optical diagnostic device that assists dermatologists in
melanoma diagnosis, announced that its CEO Rose Crane will be
interviewed live today by host Michael Yorba on Clear Channel
Business Talk Radio's The Traders Network. All interested investors
and prospective customers across the US are encouraged to tune in and
listen live via Clear Channel's nationally syndicated iHeart Radio
stream.  
The live interview details are as follows: 
Date: Today, Tuesday, February 25, 2014
 Start Time: 1:05pm CST |
11:05 am PST | 2:05 pm EST (U.S.)
 Network: Clear Channel
 Station:
DFW 1190AM Dallas-Ft. Worth 
 Host: Michael Yorba
 Live Radio Stream:
http://www.iheart.com/live/4276/?autoplay=true  
About Clear Channel: Clear Channel's Media and Entertainment division
has the largest reach of any radio or television outlet in America
with 243 million monthly listeners. It serves 150 cities through 850
owned radio stations in the U.S., as well as more than 140 stations
in New Zealand and Australia. www.clearchannel.com. 
About Michael Yorba: Mr. Yorba is the founder of Yorba Media and
featured host on Clear Channel. For the past six years he has been
integrally involved with producing and hosting a daily talk show
called Commodity Classics, and The Traders Network. 
From the fast action of the trading pit... to the power brokers
making the headlines... Michael Yorba interviews the front-page
Titans about the latest in capital markets, CEO milestones, trading
tools, real estate acquisitions and market trends. Learn how the
experts use risk management techniques to build fully diversified
portfolios and what it takes to put up big board earnings. It's a
fast moving, high-energy show that presents stocks, commodities,
bonds, forex, derivatives, real estate, political trends, technology
trends, crowd funding and impact investment insights in a new light
and keeps investors and consumers asking for more... The Traders
Network stays ahead of the curve by featuring leading market and
business professionals, sophisticated technology, and the analytics
needed to identify the most lucrative investment strategies.
Successful performance depends on finding the right opportunities.
So... shift your thinking and join us as we deliver "tomorrow's ideas
today" on Clear Channel's The Traders Network Monday - Friday from
1:00pm - 3:00pm CST live after Glenn Beck.  
About MELA Sciences, Inc. (www.melasciences.com)
 MELA Sciences is a
medical device company developing dermatology diagnostics utilizing
state-of-the-art optical imaging. The flagship product is
MelaFind(R), an FDA, PMA and CE Mark approved, non-invasive
diagnostic tool to aid dermatologists in melanoma evaluation and
diagnosis. MelaFind(R) uses a variety of visible to near-infrared
light waves to evaluate skin lesions from the surface to 2.5 mm
beneath the skin. It provides images and data on the relative
disorganization of a lesion's cell structure that provides
substantial additional perspective to aid melanoma diagnosis. MELA is
also exploring new potential uses for its core imaging technology and
algorithms. 
Twitter: MELASciencesIR or MelaFind
 Facebook: MelaFind
 StockTwits:
MELASciencesIR
 BoardVote: MELA Sciences 
A www.1800PublicRelations.com PR Event  
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2528266 
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2528269 
Contact: 
Media
MELA Sciences, Inc.
Diana Garcia Redruello
212-518-4226
dgarcia@melasciences.com
or
Investors
Catalyst Global
Toni Trigiani, David Collins
212-924-9800
mela@catalyst-ir.com 
Press/Media Contact:
Matthew Bird
MUNCmedia Public Relations
+1 (917) 409-8211
matt.bird@muncmedia.com
www.muncmedia.com 
 
 
Press spacebar to pause and continue. Press esc to stop.